CHCT at a glance
Community Healthcare Trust Inc (CHCT, SEC CIK 1631569) filed its latest 10-K annual report on February 17, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 3, 2026 and Form 4 insider filings as recently as August 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Community Healthcare Trust Inc (CHCT) reported revenue of $121.2 million (up 4.7% from FY2024) and net income of $5.1 million. Diluted EPS was $0.08.
- As of September 30, 2026, 23 institutional investment managers tracked by SignalX reported holding Community Healthcare Trust Inc (CHCT) shares worth $144.7 million in 13F-HR filings.
- The most recent insider open-market purchase reported on Form 4 was by Dupuy David H. on August 14, 2026 of 10,000 shares at $15.13 per share.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $121.2M
- +4.7% vs prior year
- Insiders · 90 days
- 0 buys · 0 sells
- No open-market trades
- 13F holders
- 23 funds
- $144.7M · −2 vs prior quarter
- Latest 8-K
- Nov 3, 2026
- Item 2.02 · Item 7.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to risk factors from the December 31, 2025 Form 10-K
- Carried-forward risks include healthcare real estate operations, tenant concentration, financing, regulatory compliance, and competition
Management Discussion & Analysis
- Rental income $32.5M, up $1.4M or 4.5% YoY, driven by acquisitions
- FFO $15.0M, up from $13.5M YoY, FFO per share $0.54 vs $0.50
- NOI $26.5M, up from $25.2M YoY, strongest operating metric disclosed
- Operating cash flow $45.1M vs $40.9M YoY, dividends $36.9M and acquisitions $28.5M
- Outlook: four-property pipeline $99.0M, higher rates and floating-rate debt remain headwinds
AI summary of the CHCT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Third-quarter earnings release for period ended September 30, 2026
- Investors should review Exhibit 99.1 for financial results and management commentary
Item 7.01: Regulation FD Disclosure
- Q3 2026 supplemental information furnished for the quarter ended September 30, 2026
- Investor presentation prepared for meetings with current and potential investors
Item EX-99.1: Item EX-99.1
- Q3 net income $3.1M, or $0.09 per diluted share, versus $1.6M and $0.03 year over year
- FFO $0.54 and AFFO $0.58 per share, up 8.0% and 3.6% year over year respectively
Item EX-99.2: Item EX-99.2
- 3Q 2026 revenue $32.4M, NOI $26.5M, and AFFO $16.0M, all higher than 2Q 2026
- AFFO per share $0.58 exceeded the $0.33 quarterly dividend, supporting dividend coverage
Item EX-99.3: Item EX-99.3
- Q2 2026 revenue $31.2M, up 7% YoY; AFFO/share $0.56, up 12%; FAD $13.0M, up 15%
- Quarterly dividend reduced from $0.48 to $0.33 per share, retaining $25M-$30M over 24 months for growth
Item 7.01: Regulation FD Disclosure
- Supplemental Information for Q2 ended June 30, 2026, furnished for investor review
- Strategic Plan Presentation for Q2 ended June 30, 2026, highlights management’s strategy and priorities
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 earnings release for quarter ended June 30, 2026
- Results and management commentary available in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- Q2 net income $2.4M, or $0.06 per diluted share, versus a $12.6M loss in Q2 2025
- AFFO $0.56 per share, up from $0.50, supporting a reduced dividend payout ratio of approximately 60%
Item EX-99.2: Item EX-99.2
- Portfolio expanded to 197 properties and $1.25B gross real estate investments, including the $28.5M Nobis Rehabilitation Hospital acquisition
- Q2 revenue $31.2M and NOI $25.4M, while AFFO rose to $15.4M, or $0.56 per diluted share
Item 5.07: Submission of Matters to a Vote of Security Holders
- 25,222,430 shares represented, approximately 88.27% of outstanding shares, indicating strong meeting participation
- All six director nominees elected to one-year terms expiring 2027, with Lawrence Van Horn receiving the fewest votes
AI summaries of CHCT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CHCT
Don't miss the next CHCT filing
- Alerts as it files. A push when CHCT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CHCT, by share count.
- Ask anything. An AI agent that reads every CHCT filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Stach Leigh Ann | A | Aug 18, 2026 | 14,810 | $15.46 |
| Monroe William G. IV | A | Aug 18, 2026 | 27,573 | $15.46 |
| Dupuy David H. | A | Aug 18, 2026 | 26,853 | $15.46 |
| Stach Leigh Ann | F | Aug 14, 2026 | 4,983 | $16.14 |
| Dupuy David H. | Buy | Aug 14, 2026 | 10,000 | $15.13 |
| Hensley Robert Z | Buy | Aug 11, 2026 | 8,000 | $15.21 |
| Dupuy David H. | A | Jul 30, 2026 | 15,573 | - |
| Monroe William G. IV | A | Jul 30, 2026 | 10,163 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $112.8M | $115.8M | $121.2M | |
| Net Income | $7.7M | -$3.2M | $5.1M | |
| Net Margin | 6.8% | -2.7% | 4.2% | |
| Balance Sheet | ||||
| Total Assets | $945.4M | $992.6M | $990.8M | |
| Equity | $513.3M | $476.0M | $429.4M | |
| ROE | 1.5% | -0.7% | 1.2% | |
| Per Share | ||||
| EPS | $0.20 | $-0.23 | $0.08 | |
| Cash Flow | ||||
| Operating CF | $61.4M | $58.9M | $56.4M | |
Source: XBRL data in Community Healthcare Trust Inc (CHCT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate CHCT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 23 | $144.7M |
| Q2 2026 | 25 | $196.2M |
| Q1 2026 | 25 | $165.0M |
| Q4 2025 | 23 | $172.8M |
| Q3 2025 | 26 | $175.3M |
| Q2 2025 | 27 | $174.7M |
| Q1 2025 | 24 | $140.1M |
| Q4 2024 | 20 | $134.1M |
- BlackRock+370.1K (+14%)
- Invesco Ltd+87.9K (+9%)
- Morgan Stanley+70.2K (+59%)
- JPMorgan Chase & Co+54.3K (+28%)
- Ameriprise Financial+17.0K (+3%)
- AQR Capital Management−316.3K (-71%)
- Two Sigma Investments−212.2K (-37%)
- Millennium Management−143.3K (-33%)
- Dimensional Fund Advisors−90.0K (-31%)
- Bank of America Corp−87.2K (-73%)
- Citadel Advisors LLC+18.6K
- FMR LLC (Fidelity)−87.3K
- Principal Financial Group−44.4K
- Renaissance Technologies LLC−14.9K
Source: 13F-HR filings on SEC EDGAR (aggregated from 193 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CHCT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
8-K current reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Nov 3, 2026 | - | Analysis | - |
| 10-Q | Nov 3, 2026 | Sep 30, 2026 | Analysis | |
| 4 | Aug 18, 2026 | - | - | - |
| 4 | Aug 18, 2026 | - | - | - |
| 4 | Aug 18, 2026 | - | - | - |
| 4 | Aug 17, 2026 | - | - | - |
| 4 | Aug 12, 2026 | - | - | - |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 10-Q | Aug 4, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Aug 3, 2026 | - | - | - |
| 4 | Aug 3, 2026 | - | - | - |
| 4 | Aug 3, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | May 26, 2026 | - | - | |
| 4 | May 26, 2026 | - | - | |
| 4 | May 26, 2026 | - | - | |
| 4 | May 26, 2026 | - | - | |
| 4 | May 26, 2026 | - | - | |
| SC 13G | May 15, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - | |
| 4 | May 8, 2026 | - | - |
Related Real Estate companies
- AKR · ACADIA REALTY TRUSTReal Estate Investment Trusts
- ACR · ACRES Commercial Realty Corp.Real Estate Investment Trusts
- ADAM · ADAMAS TRUST, INC.Real Estate Investment Trusts
- ALX · ALEXANDERS INCReal Estate Investment Trusts
- ARE · Alexandria Real Estate EquitiesReal Estate Investment Trusts
- PINE · Alpine Income Property Trust, Inc.Real Estate Investment Trusts
- AAT · American Assets Trust, Inc.Real Estate Investment Trusts
- AHR · American Healthcare REIT, Inc.Real Estate Investment Trusts
CHCT SEC filings: frequently asked questions
Which institutions hold CHCT stock?
As of September 30, 2026, the largest Community Healthcare Trust Inc (CHCT) holders among the 13F filers tracked by SignalX were BlackRock ($42.7 million), Vanguard Portfolio Management LLC ($20.6 million), Vanguard Capital Management LLC ($16.6 million), Invesco Ltd ($15.1 million), State Street Corp ($10.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CHCT's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Community Healthcare Trust Inc (CHCT) reported revenue of $121.2 million (up 4.7% from FY2024) and net income of $5.1 million. Diluted EPS was $0.08. The figures come from the XBRL data in the 10-K.
What did CHCT report in its latest 8-K?
Community Healthcare Trust Inc (CHCT) filed an 8-K on November 3, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Third-quarter earnings release for period ended September 30, 2026.
What are the latest CHCT SEC filings?
Community Healthcare Trust Inc (CHCT) filed its latest 10-K annual report on February 17, 2026, a 10-Q quarterly report on November 3, 2026, an 8-K current report on November 3, 2026 and a Form 4 insider filing on August 18, 2026.
What is CHCT's SEC CIK number?
Community Healthcare Trust Inc (CHCT)'s SEC Central Index Key (CIK) is 1631569. EDGAR lists every CHCT filing under that number.
Ask anything about CHCT
The research agent reads CHCT's filings, financials, insider trades and 13F holders, then answers with sources.